Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.
3 Unpopular Stocks That Concern Us
SAN DIEGO , April 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2026 following the close of market on Thursday, April 30, 2026....
3 Reasons to Avoid ILMN and 1 Stock to Buy Instead
David P. King nominated to support next phase of growth and innovation; Frances Arnold, Robert S. Epstein, and Gary S. Guthart to retire from the Board
1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
SAN DIEGO , March 18, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded...
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders